medRxiv
June 16, 2022
Caroline L. Alves, Thaise G. L. de O. Toutain, Joel Augusto Moura Porto et al.
preprint
There is a growing interest in the medical use of psychedelic substances as preliminary studies using them for psychiatric disorders have shown positive results. In particularly, one of these substances is N,N-dimethyltryptamine (DMT) an agonist serotonergic psychedelic that can induce profound alterations in state of consciousness. In this work, we propose a computational method based on...
medRxiv
May 27, 2022
S. P. Singleton, J. B. Wang, M. Mithoefer et al.
preprint
3,4-methylenedioxymethamphetamine-assisted therapy (MDMA-AT) for post-traumatic stress disorder (PTSD) has demonstrated promise in multiple clinical trials. MDMA is hypothesized to facilitate the therapeutic process, in part, by decreasing fear response during fear memory processing while increasing extinction learning retention. The acute administration of MDMA in healthy controls modifies...
medRxiv
April 16, 2022
Yann Barguil, Laura Chiaradia, Guy Southwell et al.
preprint
Abstract Among young consumers of cannabis, a brief psychotic disorder (BPD) can be either the clinical manifestation of acute cannabis psychosis (ACP) or an announcement of schizophrenia’s onset. Clinicians are faced with the difficulty of making a differential diagnosis between disorders of the schizophrenic field and disorders induced by cannabis. To date, no clinical or even less...
medRxiv
March 2, 2022
Maggie Kiraga, Kim P. C. Kuypers, Malin V. Uthaug et al.
preprint
Abstract Anxiety disorders are the most common type of psychiatric disorders among Western countries. Evidence-based treatment modalities including pharmacological and cognitive-behavioral therapy result in relatively low response rates (average range: 51 - 58%). Historical and recent research suggests psychedelic drugs may be efficacious in alleviating anxiety-related symptoms among healthy...
medRxiv
February 19, 2022
S. Schwartz, Alice Clerget, Lampros Perogamvros
preprint
Background: Nightmare disorder (ND) is characterized by dreams with strong negative emotions occurring during rapid-eye movement (REM) sleep. ND is mainly treated by imagery rehearsal therapy (IRT), where the patients are asked to change the negative story line of their nightmare to a more positive one. Methods: We used targeted memory reactivation (TMR) during REM sleep to strengthen...
medRxiv
January 31, 2022
Deepak Cyril D’souza, Justin Raj, Suhas Ganesh et al.
preprint
Abstract Introduction Cannabis use has been associated with several psychosis outcomes including acute and persistent psychosis termed Cannabis Induced Psychotic Disorder (CIPD). The clinical and cognitive profile, course of CIPD, and the extent to which it is different from psychosis unrelated to cannabis exposure (PsyNoCan) is not clear. Methods The acute presentation and short-term (∼4...
medRxiv
January 21, 2022
Latifah Kamal, Major Pauline Godsell, Bryce P. Mulligan et al.
1 citation
preprint
Abstract Introduction Literature reviews are useful tools for communicating the breadth of scientific discovery for a given topic. Irrespective of the nature of the review, data should be communicated in effective, easy to understand ways. In trying to address these limitations of traditional scientific reviews, we propose using dynamic data driven displays that have been used in multiple other...
medRxiv
December 17, 2021
Anders S. Olsen, Anders Lykkebo-Valløe, Brice Ozenne et al.
4 citations
preprint
Abstract Background Psilocin, the neuroactive metabolite of psilocybin, is a serotonergic psychedelic that induces an acute altered state of consciousness, evokes lasting changes in mood and personality in healthy individuals, and has potential as an antidepressant treatment. Examining the acute effects of psilocin on resting-state dynamic functional connectivity implicates network-level...
medRxiv
November 24, 2021
preprint
Trait and state mindfulness modulate EEG microstates
medRxiv
June 16, 2021
Tammi R. A. Kral, Kaley Davis, Cole Korponay et al.
2 citations
preprint
Abstract Studies purporting to show changes in brain structure following the popular, eight-week Mindfulness-Based Stress Reduction (MBSR) course are widely referenced despite major methodological limitations. Here, we present findings from a large, combined dataset of two, three-arm randomized controlled trials with active and waitlist (WL) control groups. Meditation-naive participants (n=218)...
medRxiv
November 27, 2020
Maria E Fini, William J. Tyler
5 citations
preprint
ABSTRACT The dorsal anterior cingulate cortex (dACC) operates as an integrator of bottom-up and top-down signals and is implicated in both cognitive control and emotional processing. The dACC is believed to be causally involved in switching between attention networks, and previous work has linked it to cognitive performance, concentration, relaxation, and emotional distraction. The present...
medRxiv
November 16, 2020
Indie C. Garwood, S. Chakravarty, Jacob Donoghue et al.
preprint
Abstract Ketamine is an NMDA receptor antagonist commonly used to maintain general anesthesia. At anesthetic doses, ketamine causes bursts of 30-50 Hz oscillations alternating with 0.1 to 10 Hz oscillations. These dynamics are readily observed in local field potentials (LFPs) of non-human primates (NHPs) and electroencephalogram (EEG) recordings from human subjects. However, a detailed...
medRxiv
May 21, 2020
Natália Bezerra Mota, Janaína Weissheimer, Marina Ribeiro et al.
7 citations
preprint
Neuroscience and psychology agree that dreaming helps to cope with negative emotions and learn from experience. The current global threat related to the COVID-19 pandemic led to widespread social isolation. Does dreaming change and/or reflect mental suffering? To address these questions, we applied natural language processing tools to study 239 dream reports from 67 individuals either before...
medRxiv
December 12, 2019
Ron Shore, Paul Ioudovski, Craig Goldie et al.
8 citations
preprint
Abstract We conducted a scoping review on psilocybin-assisted therapy for addiction, depression, anxiety and post-traumatic stress disorder. Psilocybin is a naturally-occurring tryptophan derivative found in species of mushroom with psycho-active properties. From 2022 records identified by database searching, 40 publications were included in the qualitative synthesis from which we identified 9...
medRxiv
September 29, 2019
Lorenzo Pasquini, Fernanda Palhano-Fontes, Draulio B Araujo
24 citations
preprint
Abstract Background Neuroimaging studies have just begun to explore the acute effects of psychedelics on large-scale brain networks’ functional organization. Even less is known on the neural correlates of subacute effects taking place days after the psychedelic experience. This study explores the subacute changes of primary sensory brain networks and networks supporting higher-order affective...
medRxiv
W. M. Green, Sanket B Raut, F.l.j. James et al.
4 citations
preprint
Abstract Post-Traumatic Stress Disorder (PTSD) causes broad impairments affecting quality of life. However, despite current treatment many people with PTSD do not fully recover. MDMA assisted psychotherapy has emerged as a new therapy for PTSD and its comorbidities. We aimed to analyse the current evidence for MDMA assisted psychotherapy in PTSD and associated quality of life, and physiological...
medRxiv
Klemens Egger, Daniel Meling, Firuze Polat et al.
preprint
Abstract Both meditation and psychedelics are widely studied for their therapeutic potential in mental health. Recent research suggests potential synergies between mindfulness practice and psychedelics, though empirical studies have primarily focused on psilocybin. This study investigates the distinct and combined effects of mindfulness practice and an ayahuasca-inspired formulation containing...